Similarly, the TGF-β1 signaling pathway was found to regulate the EMT of gastric cancer cells via miRNA-181b overexpression; the latest resulted in targeting the Tissue Inhibitor of Metalloproteinases 3 (TIMP3) gene through the Smad2/3/4-dependent pathway [49]. Here, SMAD2 is linked to gastric cancer.